Articole
Publicații științifice
Intraocular pressure modifications in patients with acute central/hemicentral retinal vein occlusions
June 2021
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Macular atrophy incidence and progression in eyes with neovascular age-related macular degeneration treated with vascular endothelial growth factor inhibitors using a treat-and-extend or a pro re nata regimen. Four year results of the Manex study
Source: International Journal of Development Research
Vol. 11, Issue 05, pp.46945-46946
May 2021
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Long-term anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: the Latar study
Source: International Journal of Development Research
Vol. 11, Issue 04, pp.46571-46572
April 2021
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Outcomes in retinal vein occlusions presenting with poor visual acuity treated with anti-vascular endothelial growth factor therapy. prognosis and predictive factors
Source: International Journal of Development Research
Vol. 11, Issue 04, pp.46111-46112
April 2021
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Bilateral central retinal vein occlusion in a 40-year-old man with severe coronavirus disease 2019 (covid-19) pneumonia
Source: International Journal of Development Research
Vol. 11, Issue 03, pp.45563-45564
March 2021
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
The impact of race on short term treatment response to bevacizumab in diabetic macular edema
Source: International Journal of Current Research
Vol. 13, Issue 02, pp.16147-16148
February 2021
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Spectral-domain oct analysis of risk factors for macular atrophy development in the harbor study for neovascular age-related macular degeneration
Source: International Journal of Current Research
Vol. 12, Issue 12, pp.15081-15082
December 2020
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Clinical characteristics and outcome of posterior cystoid macular degeneration in chornic central serous chorioretinopathy
Source: Retina - The Journal of Retinal and Vitreous Diseases
Vol. 10, Issue 08, pp. 39687-39688
August 2020
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy
Source: International Journal of Development Research
Vol. 10, Issue 07, pp. 37858-37859
July 2020
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Response of neovascular central serous chorioretinopathy to an extended upload of anti-vegf agents
Source: International Journal of Development Research
Vol. 10, Issue 06, pp. 36286-36288
June 2020
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Comment on “Microvascular changes after conbercept therapy in central retinal vein occlusion analyzed by optical coherence tomography angiography”
May 2020
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Hawk and Harrier: phase 3, multicenter, randomizaed, double-masked trials of brolucizumab for neovascular age-related macular degeneration
Source: International Journal of Development Research
Vol. 10, Issue 04, pp. 35070-35071
April 2020
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Management of the open angle glaucoma in patients with central/hemicentral retinal vein occlusions
Source: IJO - International Journal of Ophthalmology
Volume 12, Issue 3, pp.436-441
March 2020
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Macular atrophy in neovascular age-related macular degeneration
Source: International Journal of Development Research
Vol. 10, Issue 03, pp. 34352-34354
March 2020
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Comment on “Intravitreal conbercept injection for neovascular age-related macular degeneration”
Source: IJO - International Journal of Ophthalmology
Volume 13, Issue 2, p.362-364
February 2020
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Re: van Dijk et al: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: The PLACE trial
January 2020
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
The evolution of fibrosis and atrophy and their relationship with visual outcomes in Asian persons with neovascular age-related macular degeneration
Source: International Journal of Development Research
Volume 09, Issue 12, pp. 32444-32445
December 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Ten-year treatment outcomes of neovascular age-related macular degeneration from two regions
Source: International Journal of Development Research
Volume 09, Issue 11, pp. 31351-31352
November 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Optical coherence tomography angiography findings in chronic central serous chorioretinopathy after photodynamic therapy
Source: International Journal of Development Research
Volume 09, Issue 10, pp. 30921-30923
October 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (csc) diagnosed by swept source optical coherence tomography angiography (ss octa)
Source: International Journal of Development Research
Volume 09, Issue 09, pp.29982-29983
September 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Re: Chan et al: Disorganization of Retinal Inner Layers and Ellipsoid Zone Disruption Predict Visual Outcomes in Central Retinal Vein Occlusion. (Ophthalmol Retina. 2019;3:83-92)
September 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion
September 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Re: Bailey et al: Intralesional macular atrophy in anti-vascular endothelial growth factor therapy for age-related macular degeneration in the IVAN trial (Ophthalmology. 2019;126:75–86)
September 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Comment on „The thickness and volume of the choroid, outer retinal layers and retinal pigment epithelium layer changes in patients with diabetic retinopathy”
Source: IJO - International Journal of Ophthalmology
Volume 12,Issue 08, p.1366-1368
August 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Patient Characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage
Source: International Journal of Development Research
Volume 09, Issue 07, pp.28800-28801
July 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Loss of peak vision in retinal vein occlusion patients treated for macular edema
Source: International Journal of Development Research
Volume 09, Issue 07, pp.28783-28784
July 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser
Source: International Journal of Current Research
Volume 11, Issue 06, pp.4439-4440
June 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
A two-year study of diffused retinal pigment epitheliopathy treated with half-dose photodynamic therapy guided by simultaneous angiography and optical coherence tomography
Source: International Journal of Current Research
Volume 11, Issue 06, pp.4480-4481
June 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Ischemic retinal vein occlusion: Characterizing the more severe spectrum of retinal vein occlusion
June 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Predictive Factors of Response to Mineralocorticoid Receptor Antagonist in Nonresolving Central Serous Chorioretinopathy
May 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Comment on “Correlation between macular ganglion cell-inner plexiform layer thickness and visual acuity after resolution of the macular edema secondary to central retinal vein occlusion”
Source: IJO - International Journal of Ophthalmology
April 2019, Volume 12, Issue 4, pp.695-696
April 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Central serous chorioretinopathy in elderly subjects: angiographic and tomographic characteristics
Source: International Journal of Current Research
February 2019, Volume 11, Issue 02, pp.1614-1615
February 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 Phoenix Study
February 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Choroidal thickness changes stratified by outcome in real-world treatment of diabetic macular edema
Source: Graefe’s Archive for Clinical and Experimental Ophthalmology
Volume 257, Issue 1, pp. 241–242
January 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Re: Berry et al: Association of Disorganization of Retinal Inner Layers with Ischemic Index and Visual Acuity in Central Retinal Vein Occlusion
January 2019
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting
December 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Comment on “Intravitreal dexamethasone implants for diabetic macular edema”
December 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience
Graefe’s Archive for Clinical and Experimental Ophthalmology
Volume 256, Issue 11, pp. 2269–2270
November 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Clinical Features of Central Serous Chorioretinopathy With Type 1 Choroidal Neovascularization
November 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Re: Li et al.: Long-term Assessment of Macular Atrophy in Patients with Age-Related Macular Degeneration Receiving Anti-Vascular Endothelial Growth Factor
October 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Half-time photodynamic therapy in treatment of chronic central serous chorioretinopathy
October 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Real-world outcomes of anti-vascular endothelial growth factor therapy in diabetic macular edema in the united states
October 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Vision Outcomes Following Anti–Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice
September 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Guidelines on diabetic eye care. the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings
September 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
The fate of eyes with wet AMD beyond 4 years of anti-VEGF therapy
Graefe’s Archive for Clinical and Experimental Ophthalmology
Volume 256, Issue 8, pp. 1551–1552
August 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
What We Have Learned From the Ocular Hypertension Treatment Study
August 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Comment on “Management strategies in malignant glaucoma secondary to antiglaucoma surgery”
August 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Ocular hypertension in patients with central/hemicentral retinal vein occlusions: cumulative prevalence and management
July 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
July 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study
Graefe’s Archive for Clinical and Experimental Ophthalmology
Volume 256, Issue 6, pp. 1209–1210
June 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Outcomes of Patients Initially Treated with Intravitreal Bevacizumab for Central Retinal Vein Occlusion: Long-Term Follow-Up
May 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Inner nuclear layer cystoid spaces are a poor prognostic factor in typical age-related macular degeneration and polypoidal choroidal vasculopathy
Graefe’s Archive for Clinical and Experimental Ophthalmology
Volume 256, Issue 3, pp. 627–629
March 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome
February 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Comments to: Restoration of photoreceptors in eyes with diabetic macular edema.
January 2018
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Comments to: Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal
EJO - European Journal of Ophthalmology
Volume 27, Issue 6, pp. 627 - 800, e175 - e195
December 2017
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion
December 2017
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Comment on “Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion”
September 2017
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion
Graefe’s Archive for Clinical and Experimental Ophthalmology
olume 255, Issue 5, pp. 1043–1044
May 2017
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Central Retinal Vein Occlusion
April 2017
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Dexamethasone intravitreal implant in retinal vein occlusion:real-life data from a prospective, multicenter clinical trial
Graefe’s Archive for Clinical and Experimental Ophthalmology
Volume 255, Issue 2, pp. 427–428
February 2017
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France
Graefe’s Archive for Clinical and Experimental Ophthalmology
Volume 255, Issue 1, pp. 211–212
January 2017
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Comments to: Long-term efficacy and safety of intravitreal dexamethasone implant for the treatment of diabetic macular edema
December 2016
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Comment on: „Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naive eyes with macular edema secondary to CRVO: prospective randomized study”
Graefe’s Archive for Clinical and Experimental Ophthalmology
Volume 254, Issue 12, pp. 2477–2478
December 2016
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Pro-permeability Factors in Diabetic Macular Edema; The Diabetic Macular Edema Treated With Ozurdex Trial
October 2016
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Correspondence – Comment on: „Central retinal vein occlusion: modifying current treatment protocols”
Eye - The Scientific Journal of the Royal College of Ophthalmologists
Volume 30, Issue 10, p.1395-1396
October 2016
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Correspondence – Comment on: „Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab”
Eye - The Scientific Journal of the Royal College of Ophthalmologists
Volume 30, Issue 6, p.896-897
June 2016
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up (BERVOLT study: bevacizumab for RVO long-term follow-up)
Graefe’s Archive for Clinical and Experimental Ophthalmology
Volume 254, Issue 5, p.1023–1024
May 2016
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study
February 2016
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romani
Pro-permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; The Ozurdex for Retinal Vein Occlusion (ORVO) Study
January 2016
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Letter to the Editor: „Treat-and-Extend Intravitreal Bevacizumab for Branch Retinal Vein Occlusion”
OSLI Retina - Ophthalmic Surgery, Lasers & Imaging Retina
Volume 46, Issue 10, p.994
December 2015
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Correspondence – Comment on: „The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary”
Eye - The Scientific Journal of the Royal College of Ophthalmologists
Volume 29, Issue 12, p.1631-1632
December 2015
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
Ophthalmic Technology Assessment: therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology
November 2015
- Dan Călugăru, Mihai Călugăru
- University of Medicine Cluj-Napoca, Romania
